Gary Jacob
Algemeen Directeur bij OKYO PHARMA LIMITED
Vermogen: 67 180 $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| John Brancaccio | M | 76 |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 20 jaar |
| Bernard Denoyer | M | 77 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 14 jaar |
| Willy Simon | M | 72 | 9 jaar | |
| Keeren Shah | F | 47 | 8 jaar | |
| Vanila Singh | M | 53 | 4 jaar | |
| Gabriele Cerrone | M | 52 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 14 jaar |
| Kaouthar Lbiati | M | 45 | 2 jaar | |
| John Cavan | M | 65 | 8 jaar | |
| Timothy Block | M | 69 | 11 jaar | |
| Michael Dubin | M | 68 | 3 jaar | |
| Paul Spencer | M | - | 2 jaar | |
| Raj Patil | M | 66 | 6 jaar | |
| Daniel Trepanier | M | - | 5 jaar | |
| Daren Ure | M | - | 5 jaar | |
| John Bell | M | 71 |
University of Oxford
| 35 jaar |
| Jules S. Jacob | M | - | 7 jaar | |
| William Clementi | M | - | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Kunwar Shailubhai | M | 67 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 9 jaar |
| Hugh Grant | M | 65 | 20 jaar | |
| Robert Foster | M | 65 | 7 jaar | |
| Christopher Chipman | M | 50 | 3 jaar | |
| Craig C. Talluto | M | - |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 8 jaar |
| Julia Black | F | - |
University of Oxford
| 8 jaar |
| Robin N. Lowe | M | 59 |
University of Oxford
| 4 jaar |
| James Sapirstein | M | 63 | 4 jaar | |
| Michael Barrow | M | - |
University of Oxford
| 3 jaar |
| Matt Greenwood | M | - |
University of Oxford
| 3 jaar |
| Kevin L. Thurm | M | 62 |
University of Oxford
| 1 jaar |
| Daniel Kapi | M | - |
University of Oxford
| 5 jaar |
| Philip Needleman | M | - |
G.D. Searle LLC
| 4 jaar |
| Richard Berman | M | 81 | 1 jaar | |
| Yat Hung Fu | M | 60 |
University of Oxford
| 6 jaar |
| Ick-Soo Kim | M | 68 |
University of Oxford
| 3 jaar |
| Man Wai Chiu | M | 55 |
University of Oxford
| 5 jaar |
| Theresa Matkovits | M | 56 | 3 jaar | |
| Peter Wijngaard | M | 61 | 3 jaar | |
| Doron Junger | M | - |
University of Oxford
| 6 jaar |
| Shirley Cunningham | F | 63 | 15 jaar | |
| Antony J. Fairbanks | M | - |
University of Oxford
| 3 jaar |
| Rupert Charles de Borchgrave d'Altena | M | - |
University of Oxford
| 7 jaar |
| Christopher McGuigan | M | 65 | 3 jaar | |
| Anand Reddi | M | 42 | 2 jaar | |
| Judson A. Cooper | M | 65 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | - |
| Joshua D. Schein | M | 63 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | - |
| Randall K. Johnson | M | 77 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 8 jaar |
| Thomas H. Adams | M | 81 | 6 jaar | |
| Tamar Howson | F | 75 | 2 jaar | |
| William Guttman | M | 63 |
University of Oxford
| 5 jaar |
| Arnold Lippa | M | 77 | 8 jaar | |
| Simon H. Thomas | M | 64 |
University of Oxford
| 5 jaar |
| Stephen Swaffield | M | 61 |
University of Oxford
| 6 jaar |
| Duraiswami Narain | M | 60 | 20 jaar | |
| Byron Auguste | M | 56 |
University of Oxford
| 4 jaar |
| James Allen | M | 57 |
University of Oxford
| 5 jaar |
| Matthew Ridgwell | M | 59 |
University of Oxford
| 4 jaar |
| Diego Muñoz Tamayo | M | 67 |
University of Oxford
| 1 jaar |
| Steven Lang | M | - |
University of Oxford
| 3 jaar |
| Michael Stein | M | 60 |
University of Oxford
| 4 jaar |
| Chee Peng Ng | M | 54 |
University of Oxford
| 4 jaar |
| Brendan Ludden | M | - |
University of Oxford
| 5 jaar |
| Jason Bush | M | - |
University of Oxford
| 3 jaar |
| Christine Whyte | M | - |
University of Oxford
| 4 jaar |
| AILSA HARRIS | F | - |
University of Oxford
| 4 jaar |
| Steven Paul Frederick Ward | M | 53 |
University of Oxford
| 3 jaar |
| Nicola Kerslake | F | - |
University of Oxford
| 3 jaar |
| Ignatius Low | M | - |
University of Oxford
| 4 jaar |
| Guan Hong Yap | M | 60 |
University of Oxford
| 4 jaar |
| Duncan Fatkin | M | - |
University of Oxford
| 4 jaar |
| Michael Hewett | M | - |
University of Oxford
| 3 jaar |
| Chris Watt | M | - |
University of Oxford
| 4 jaar |
| Eleni D. Dendrinou-Louri | M | 70 |
University of Oxford
| 4 jaar |
| Jih-Shian Yeo | M | 55 |
University of Oxford
| 4 jaar |
| Matthew James Whittell | M | - |
University of Oxford
| 4 jaar |
| Catherine Powell | F | 56 |
University of Oxford
| 4 jaar |
| Reid Hoffman | M | 56 |
University of Oxford
| 3 jaar |
| Philippa Aldrich | F | - |
University of Oxford
| 4 jaar |
| Simon Munton Bullivant | M | - |
University of Oxford
| 4 jaar |
| Carl Dunton | M | 52 |
University of Oxford
| 4 jaar |
| Eric Maisel | M | 58 |
University of Oxford
| 2 jaar |
| Mark Gallagher | M | - |
University of Oxford
| 4 jaar |
| Joshua Lewis | M | 62 |
University of Oxford
| 4 jaar |
| Trevor D. Traina | M | 56 |
University of Oxford
| 1 jaar |
| Paul Markovich | M | - |
University of Oxford
| 2 jaar |
| Koosum P. Kalyan | F | 68 |
University of Oxford
| 4 jaar |
| Jonathan Hepple | M | 53 |
University of Oxford
| 3 jaar |
| Maria Teresa H. D. S. M. Roque Dal Fabbro | F | - |
University of Oxford
| 3 jaar |
| Matthew James Benson | M | 58 |
University of Oxford
| 4 jaar |
| Robert Baugh | M | - |
University of Oxford
| 4 jaar |
| Jeffrey Moore | M | - |
University of Oxford
| 4 jaar |
| Carolyn Anne Prowse | F | 52 |
University of Oxford
| 4 jaar |
| Christoph Matthias Widmer | M | 57 |
University of Oxford
| 4 jaar |
| Joanne Warner | M | 62 |
University of Oxford
| 3 jaar |
| Neill Penney | M | - |
University of Oxford
| 4 jaar |
| Emre Yigit | M | - |
University of Oxford
| 4 jaar |
| Natalia Gurushina | M | - |
University of Oxford
| 5 jaar |
| James C. Clarke | M | - |
University of Oxford
| 4 jaar |
| Mark Brooker | M | 52 |
University of Oxford
| 4 jaar |
| Andrew Edward Anson | M | 59 |
University of Oxford
| 3 jaar |
| Wai Keong Loh | M | - |
University of Oxford
| 3 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigd Koninkrijk | 72 | 72.73% |
| Verenigde Staten | 32 | 32.32% |
| Australië | 1 | 1.01% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Gary Jacob
- Persoonlijk netwerk